In contrast, CD8+ TIL from melanoma tumors did not exhibit this type of metabolic plasticity and consequently demonstrated a loss of proliferation and Granzyme B production, reflecting their diminished capacity for tumor control. This evidence concerns the gene CD8A and melanoma.